An Advanced Surgical Dressing for High-risk Patients Undergoing Breast Cancer Surgery: A Case-control Study

Antonella Nicotera(Collaborative Group (United States)), Fabrizio Malàn(CTO Hospital), Maria Rosa D’Anna(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), M. Brunetti, Ada Ala, Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Pietro Maria Ferrando(CTO Hospital)

Plastic & Reconstructive Surgery Global Open

November 1, 2021

10.1097/gox.0000000000003911

Cited by 3

Related Papers

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

|Journal of Clinical Oncology|2015|2.2k

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders

|Leukemia|2013|305

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

|Blood|2011|268

Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma

|Journal of Clinical Oncology|2010|268

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

|Blood|2008|253